Indivior (INDV)

Sector: Pharma and Biotech     Index: FTSE 250
-1.70%
-7.10p
412.20p
17:17 18/08/17
412.20p
17:17 18/08/17
DAILY VARIATION
-1.70%
-7.10p
VOLUME
862,338
REAL TIME BATS
412.20p
17:36 18/08/17
-1.51%
-6.30p
DATA
52 Week High
418.20p
52 Week Low
279.30p
Shares Issued
721.22m
Market Cap
£2,972.85m
RiskGrade
216
Beta
0.68
MENU

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 14.1% 30.6%
ROCE 75.6%
Latest F'cast
P/E 15.1 13.0
PEG 5.1 -2.0
Pr/Revenue 3.6 3.6
Pr/Book -12.9
Latest F'cast
Revenue 4.3% 14.1%
PBT -65.6% n/a
EPS 2.9% 32.1%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 1,115.00 561.00 58.00¢ 4.0 0.0 n/a n/a 0.0%
2015-12-31 1,014.00 285.00 34.00¢ 8.1 -0.2 -41% 12.70¢ 4.6%
2016-12-31 1,058.00 98.00 35.00¢ 10.4 3.5 3% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 828.52 253.68 24.70p 13.0 -1.6 -8% 0.00p 0.0%
2018-12-31 857.10 260.79 26.00p 12.2 2.3 5% 0.00p 0.0%

Regulatory News

slide to see more

Newspaper Links

No results found